HealthDay News — For women with breast cancer (BC), BRCA mutations are associated with increased risk of developing breast implant–associated anaplastic large cell lymphoma (BIA-ALCL), according to a ...

Prutsch, N., et al. (2024) STAT3 couples activated tyrosine kinase signaling to the oncogenic core transcriptional regulatory circuitry of anaplastic large cell lymphoma. Cell Reports Medicine ...

Anaplastic large cell lymphoma ... Together, these efforts are instrumental in constructing a more comprehensive treatment framework that marries targeted therapy with precision diagnostics.

Savage KJ, Harris NL, Vose JM, et al: ALK- anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK+ ALCL and peripheral T-cell lymphoma, not otherwise specified: ...

From 2020 to 2022, the investigators treated 15 adults with ALK-positive ALCL with off-label brigatinib at a dozen centers in the French Lymphoma Study Association.

Anaplastic large cell lymphoma (ALCL) belongs to the subgroup of non-Hodgkin's lymphomas and is a rare but aggressive form of T-cell lymphoma that usually occurs in children and young adults.

In a reversal of a previous decision, NICE has approved a form of personalised cancer treatment with CAR T-cell therapy for refractory or relapsed large B-cell lymphoma.

WEDNESDAY, June 25, 2025 (HealthDay News) -- For women with breast cancer (BC), BRCA mutations are associated with increased risk of developing breast implant–associated anaplastic large cell ...